eli lilly retatrutide trial results just announced striking Phase 3 for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Lilly's triple agonist achieves 16.8%

According to Engel, he started taking Ozempic in 2023, after his doctor prescribed the drug to help him manage his diabetes

Medicaid in New York provides coverage for a variety of services beyond federal minimums, including dental, vision, mental health, and substance abuse treatments, and has recently expanded benefits for pregnant women and dental services

Compared to a company like Sesame Care, which provides access to doctors who can prescribe GLP-1s, Found may be less expensive

Severe dehydration can lead to very serious problems

Some compounding pharmacies might make semaglutide tablets themselves, but these drugs arent FDA-approved or inspected